A client is scheduled for the first fingolimod dose. Which p… | MyMerci
Adverse Effects/Contraindications/Interactions PPT
Question

A client is scheduled for the first fingolimod dose. Which plan is appropriate?

Explanation
Fingolimod can cause first-dose bradycardia and atrioventricular conduction delay. Required baseline assessment and at least 6 hours of observation with pulse and blood-pressure checks are part of safe initiation.
Next question on this topicA nurse is reviewing the morning lab results for an adult client receiving warfarin for at…

In-depth explanation

Quick answer
Treat the first fingolimod dose as a monitored cardiac event.

Why this is correct
Additional or overnight monitoring is required when post-dose findings meet labeled risk criteria.

Easy analogy or mental picture
Build a medication-safety chain: identify the new cue, connect it to the drug mechanism or labeled limitation, stop preventable exposure, stabilize the client, and verify a measurable response.

Memory hook
Drug, urgent cue, protective action, and reassessment endpoint.

NCLEX decision rule
Choose the action that prevents the most immediate medication-related harm while preserving indicated treatment and required monitoring.

Why the other choices are wrong
Options that continue a suspect exposure, normalize a labeled danger cue, substitute an unauthorized dose, or delay escalation leave the client at risk.
References
1DailyMed: GILENYA (fingolimod)First-dose bradycardia and observation requirements

Clinical scenario

Medication-safety review
Verify indication, current assessment, dose and route, organ function, interactions, urgent toxicity cues, authorized action, and measurable follow-up.
Browse all questions No login required

Master the NCLEX-RN with MyMerci

Thousands of NCLEX-style questions with detailed rationale — in your language. Track your progress and study smarter.

Start for free
Read in another language: English한국어日本語繁體中文Tiếng Việt

For study reference only. Always follow current clinical guidelines and your institution’s protocols.